Available to sourceHuman Prescription DrugGastrointestinal

Sodium chloride

9 mg/mL · Injection Solution

By Fresenius Kabi USA, LLC

NDC: 65219-222
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

30 BAG in 1 CASE (65219-222-25) / 250 mL in 1 BAG (65219-222-01)NDC 65219-222-25Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.